Detection and quantification of protein biomarkers from fewer than 10 cells

Molecular and Cellular Proteomics

Volumn 5, Issue 5, 2006, Pages 895-901

  Nettikadan, Saju ^a   Radke, Korinna ^a   Johnson, James ^c   Xu, Juntao ^a   Lynch, Michael ^a   Mosher, Curtis ^a   Henderson, Eric ^a,b  

^a BioForce Nanosciences Incorporated   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c Des Moines University College of Osteopathic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CELL LYSATE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN MICROARRAY; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CELL COUNT; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 33646926941     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500350-MCP200     Document Type: Article

References (30)

1. Ludwig, J. A., and Weinstein, J. N. (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 5, 845-856
2. Mikolajczyk, S. D., Song, Y., Wong, J. R., Matson, R. S., and Rittenhouse, H. G. (2004) Are multiple markers the future of prostate cancer diagnostics? Clin. Biochem. 37, 519-528
3. Liotta, L. A., Espina, V., Mehta, A. I., Calvert, V., Rosenblatt, K., Geho, D., Munson, P. J., Young, L., Wulfkuhle, J., and Petricoin, E. F., III (2003) Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 3, 317-325
4. Haab, B. B., Dunham, M. J., and Brown, P. O. (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2, RESEARCH0004
5. Zhu, H., Bilgin, M., Bangham, R., Hall, D., Casamayor, A., Bertone, P., Lan, N., Jansen, R., Bidlingmaier, S., Houfek, T., Mitchell, T., Miller, P., Dean, R. A., Gerstein, M., and Snyder, M. (2001) Global analysis of protein activities using proteome chips. Science 293, 2101-2105
6. Nielsen, U. B., and Geierstanger, B. H. (2004) Multiplexed sandwich assays in microarray format. J. Immunol. Methods 290, 107-120
7. Nielsen, U. B., Cardone, M. H., Sinskey, A. J., MacBeath, G., and Sorger, P. K. (2003) Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc. Natl. Acad. Sci. U. S. A. 100, 9330-9335
8. Wang, C. C., Huang, R. P., Sommer, M., Lisoukov, H., Huang, R., Lin, Y., Miller, T., and Burke, J. (2002) Array-based multiplexed screening and quantitation of human cytokines and chemokines. J. Proteome Res. 1, 337-343
9. Wiese, R., Belosludtsev, Y., Powdrill, T., Thompson, P., and Hogan, M. (2001) Simultaneous multianalyte ELISA performed on a microarray platform. Clin. Chem. 47, 1451-1457
10. Schweitzer, B., Roberts, S., Grimwade, B., Shao, W., Wang, M., Fu, Q., Shu, Q., Laroche, I., Zhou, Z., Tchernev, V. T., Christiansen, J., Velleca, M., and Kingsmore, S. F. (2002) Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 20, 359-365
11. Yguerabide, J., and Yguerabide, E. (1998) Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications. Anal. Biochem. 262, 157-176
12. Miller, J. C., Zhou, H., Kwekel, J., Cavallo, R., Burke, J., Butler, E. B., Teh, B. S., and Haab, B. B. (2003) Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 3, 56-63
13. Sreekumar, A., Nyati, M. K, Varambally, S., Barrette, T. R., Ghosh, D., Lawrence, T. S., and Chinnaiyan, A. M. (2001) Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res. 61, 7585-7593
14. Knezevic, V., Leethanakul, C., Bichsel, V. E., Worth, J. M., Prabhu, V. V., Gutkind, J. S., Liotta, L. A., Munson, P. J., Petricoin, E. F., III, and Krizman, D. B. (2001) Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1, 1271-1278
15. Ekins, R. P., Berger, H., Chu, F. W., Finckh, T., and Krause, F. (1998) Minuaturised immunoarrays: ultrasensitive multianalyte immunoassays on a chip. Nanobiology 4, 197-220
16. Silzel, J. W., Cercek, B., Dodson, C., Tsay, T., and Obremski, R. J. (1998) Mass-sensing, multianalyte microarray immunoassay with imaging detection. Clin. Chem. 44, 2036-2043
17. Lynch, M., Mosher, C., Huff, J., Nettikadan, S., Johnson, J., and Henderson E. (2004) Functional protein nanoarrays for biomarker profiling. Proteomics 4, 1695-1702
18. Hernandez, J., and Thompson, I. M. (2004) Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 101, 894-904
19. Yousef, G. M., and Diamandis, E. P. (2001) The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184-204
20. Balk, S. P., Ko, Y. J, and Bubley, G. J. (2003) Biology of prostate-specific antigen. J. Clin. Oncol. 21, 383-391
21. Lovgren, J., Valtonan-Andre, C., Marsal, K., Lilja, H., and Lundwall, A. (1999) Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids. J. Androl. 20, 348-355
22. Grossmann, M. E., Huang, H., and Tindall, D. J. (2001) Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. 93, 1687-1697
23. Chung, T. D., Yu, J. J, Spiotto, M. T., Bartkowski, M., and Simons, J. W. (1999) Characterization of the role of IL-6 in the progression of prostate cancer, Prostate 38, 199-207
24. Adler, H. L., McCurdy, M. A., Kattan, M. W., Timme, T. L., Scardino, P. T., and Thompson, T. C. (1999) Elevated levels of circulating interieukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma. J. Urol. 161, 182-187
25. Nakashima, J., Tachibana, M., Horiguchi, Y., Oya, M., Ohigashi, T., Asakura, H., and Murai, M. (2000) Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin. Cancer Res. 6, 2702-2706
26. Lee, Y., Lee, E. K., Cho, Y. W., Matsui, T., Kang, I. C., Kim, T. S., and Han, M. H. (2003) ProteoChip: a highly sensitive protein microarray prepared by a novel method of protein immobilization for application of protein-protein interaction studies. Proteomics 3, 2289-2304
27. Henderson, E., Mosher, C., and Lynch, M. P. (June 3, 2003) Method and apparatus for solid state molecular analysis, BioForce Nanosciences Inc., U. S. Patent 6,573,369
28. Xu, J., Lynch, M., Huff, J. L., Mosher, C., Vengasandra, S., Ding, G., and Henderson, E. (2004) Microfabricated quill-type surface patterning tools for the creation of biological micro/nano arrays. Biomed. Microdevices 6, 117-123
29. Silverton, E. W., Navia, M. A., and Davies, D. R. (1977) Three-dimensional structure of an intact human immunoglobulin. Proc. Natl. Acad. Sci. U. S. A. 74, 5140-5144
30. Wadu-Mesthrige, K., Amro, N. A., Gamo, J. C., Xu, S., and Liu, G. (2001) Fabrication of nanometer-sized protein patterns using atomic force microscopy and selective immobilization. Biophys. J. 80, 1891-1899